Accurate and rapid analysis of genome editing data from nucleases and base editors with CRISPResso2

At the time of manuscript preparation, JMG was a consultant for Beam Therapeutics, and now is employed by Beam Therapeutics. JKJ has financial interests in Beam Therapeutics, Editas Medicine, Endcadia, EpiLogic Therapeutics, Pairwise Plants, Poseida Therapeutics and Transposagen Biopharmaceuticals. JKJ's interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. JKJ is a member of the Board of Directors of the American Society of Gene and Cell Therapy. JMG and JKJ are co-inventors on patents and patent applications that describe gene editing technologies. DRL is a consultant and cofounder of Editas Medicine, Pairwise Plants and Beam Therapeutics, companies that use genome editing.Code availability. CRISPResso2 is available online at http://crispresso2. pinellolab. org, where users can run up to 4 …